Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026)
Amarin Corp Plcuk (AMRN) reported Gross Profit of $17.8 million for Q1 2026, down 29.29% year-over-year from $25.1 million in Q1 2025, and down 23.31% quarter-over-quarter from $23.2 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 14 years of Gross Profit data on file, last reported at $17.8 million in Q1 2026.
- Gross Profit for Q1 2026 came in at $17.8 million, down 29.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $113.5 million (up 52.14% YoY), and the FY2025 annual result was $120.9 million, up 48.52% from the prior year.
- Gross Profit eased to $17.8 million in Q1 2026 per AMRN's latest filing, from $23.2 million in the prior quarter.
- Over five years, Gross Profit peaked at $72.4 million in Q1 2022 and troughed at -$9.6 million in Q4 2024.
- A 5-year average of $36.9 million and a median of $42.7 million in 2023 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2024 and 2025: Gross Profit tumbled 121.2% in 2024, then surged 342.18% in 2025.
- A 5-year view of Gross Profit shows it stood at $63.6 million in 2022, then decreased by 29.05% to $45.1 million in 2023, then tumbled by 121.2% to -$9.6 million in 2024, then surged by 342.18% to $23.2 million in 2025, then slipped by 23.31% to $17.8 million in 2026.
- Business Quant data shows AMRN's Gross Profit at $17.8 million in Q1 2026, $23.2 million in Q4 2025, and $22.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.77 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Dec 31, 2023 | 45.12 Mn |
| Dec 31, 2023 | 45.12 Mn |